The Department of Pediatric Oncology is dedicated to advancing childhood cancer research through laboratory studies, translational investigation, and clinical trials. The department focuses on developing innovative therapeutic approaches while fostering an exceptional training environment for researchers.

Through its partnership with Boston Children's Hospital and the Dana-Farber/Boston Children's Cancer and Blood Disorders Center, the department conducts pediatric clinical trials aimed at improving treatment outcomes across various cancer stages.

To accelerate the transition from discovery to treatment, two bridging programs unite experts in cancer genomics, drug discovery, and clinical research. The Precision Medicine program uses tumor profiling to match patients with targeted therapies, while the Center for Pediatric Cancer Therapeutics focuses on identifying new small molecules, exploring genetic determinants, and validating treatments through advanced disease models.

Ultimately, these initiatives aim to revolutionize pediatric cancer care by developing more effective, personalized therapies.